Navamedic ASA: Invitation to 2023 2nd quarter presentation

Published: 07.08.2023

Navamedic ASA: Annual Report for 2022

Published: 28.04.2023

Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB

Published: 22.04.2023

Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million

Published: 29.03.2023

Navamedic ASA: Q4 2022 financial results

Published: 16.02.2023

Navamedic ASA: Invitation to 2022 4th quarter presentation

Published: 13.02.2023